Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
30.69%
operating margin TTM
26.92%
revenue TTM
51.85 Million
revenue per share TTM
1.8$
valuation ratios | |
|---|---|
| pe ratio | 52.45 |
| peg ratio | 0.76 |
| price to book ratio | 4.94 |
| price to sales ratio | 16.13 |
| enterprise value multiple | 53.00 |
| price fair value | 4.94 |
profitability ratios | |
|---|---|
| gross profit margin | 92.41% |
| operating profit margin | 26.92% |
| pretax profit margin | 32.82% |
| net profit margin | 30.69% |
| return on assets | 8.44% |
| return on equity | 10.28% |
| return on capital employed | 8.2% |
liquidity ratio | |
|---|---|
| current ratio | 7.28 |
| quick ratio | 7.02 |
| cash ratio | 3.38 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 438.85 |
| operating cycle | 570.46 |
| days of payables outstanding | 82.53 |
| cash conversion cycle | 487.93 |
| receivables turnover | 2.77 |
| payables turnover | 4.42 |
| inventory turnover | 0.83 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.01 |
| debt equity ratio | 0.01 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.01 |
| interest coverage | 0.00 |
| cash flow to debt ratio | 17.00 |
cash flow ratios | |
|---|---|
| free cash flow per share | 4.14 |
| cash per share | 20.78 |
| operating cash flow per share | 4.29 |
| free cash flow operating cash flow ratio | 0.97 |
| cash flow coverage ratios | 17.00 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 29.12 |
Frequently Asked Questions
When was the last time Krystal Biotech, Inc. (NASDAQ:KRYS) reported earnings?
Krystal Biotech, Inc. (KRYS) published its most recent earnings results on 04-11-2024.
What is Krystal Biotech, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Krystal Biotech, Inc. (NASDAQ:KRYS)'s trailing twelve months ROE is 10.28%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Krystal Biotech, Inc. (KRYS) currently has a ROA of 8.44%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did KRYS's net profit margin stand at?
KRYS reported a profit margin of 30.69% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is KRYS's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 7.28 in the most recent quarter. The quick ratio stood at 7.02, with a Debt/Eq ratio of 0.01.